NEW YORK – A company with expertise in detecting the presence of explosives or drugs may not be the first place someone would go for a SARS-CoV-2 test.
But Stafford, Texas-based DetectaChem is working to change that perception with its COVID-19 tests based on the automated colorimetric technology it has used for 15 years to detect explosives and narcotics. "Our core business is detection, whether it be of explosives, drugs, or now biologics," COO Travis Kisner said.